PE: What alternate strategies would have a better impact on reducing drug costs? Mendelsohn: Pushing for lower out-of-pocket ...

Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing ...

Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

Sanofi announced an expansion of its partnership with McLaren Racing. The two companies, alongside United Autosports, are ...

Which tariffs will have the most impact on the Pharma industry? Jason Waite: Thus far, the recently announced tariffs have ...

After announcing successful trial results for its lead mRNA treatment earlier this year, Regulus Therapeutics agreed to be ...

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

Market access is about aligning internal strategies with external realities that often change without warning and at a ...